Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Bokelin Pharmaceutical Packaging Technology Co., Ltd. is a specialized manufacturer of pharmaceutical packaging materials and excipients, operating as a subsidiary of the Tasly Group. Founded in 2002 and based in Tianjin, China, the company integrates design, R&D, manufacturing, and technical consulting for a wide range of products including medical plastic bottles, eye drop containers, and pharmaceutical film coating agents. Its facilities adhere to GMP standards with 100,000-level cleanroom environments, supporting an annual production capacity of over 300 million sets. Bokelin also produces high-purity pharmaceutical excipients such as Polyethylene Glycol (PEG) and various coating formulations to support the global pharmaceutical industry. The company holds numerous patents and is recognized as a national high-tech enterprise and a "Specialized and Sophisticated" SME in China. It serves as a critical supply chain partner for both its parent company and external pharmaceutical clients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Bokelin Pharmaceutical Packaging.